These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


128 related items for PubMed ID: 2661525

  • 21. Cardiovascular effects of mixed amphetamine salts extended release in the treatment of school-aged children with attention-deficit/hyperactivity disorder.
    Donner R, Michaels MA, Ambrosini PJ.
    Biol Psychiatry; 2007 Mar 01; 61(5):706-12. PubMed ID: 16899230
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Desipramine treatment of boys with attention-deficit hyperactivity disorder and tics: preliminary clinical experience.
    Riddle MA, Hardin MT, Cho SC, Woolston JL, Leckman JF.
    J Am Acad Child Adolesc Psychiatry; 1988 Nov 01; 27(6):811-4. PubMed ID: 3198572
    [No Abstract] [Full Text] [Related]

  • 24. Pediatric cardiovascular effects of imipramine and desipramine.
    Bartels MG, Varley CK, Mitchell J, Stamm SJ.
    J Am Acad Child Adolesc Psychiatry; 1991 Jan 01; 30(1):100-3. PubMed ID: 2005043
    [Abstract] [Full Text] [Related]

  • 25. Desipramine in the treatment of adolescents with attention deficit disorder.
    Gastfriend DR, Biederman J, Jellinek MS.
    Am J Psychiatry; 1984 Jul 01; 141(7):906-8. PubMed ID: 6375400
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. 2-Hydroxydesipramine and desipramine plasma levels and electrocardiographic effects in depressed younger adults.
    Stern SL, Ribner HS, Cooper TB, Nelson LD, Johnson MH, Suckow RF.
    J Clin Psychopharmacol; 1991 Apr 01; 11(2):93-8. PubMed ID: 2056147
    [Abstract] [Full Text] [Related]

  • 28. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK.
    Clin Ther; 2007 Jun 01; 29(6):1168-77. PubMed ID: 17692731
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Growth deficits and desipramine.
    Holt KG.
    J Am Acad Child Adolesc Psychiatry; 1992 Nov 01; 31(6):1167-8. PubMed ID: 1429424
    [No Abstract] [Full Text] [Related]

  • 32. Attention deficit disorder and the effect of methylphenidate on attention, behavioral, and cardiovascular functioning.
    Brown RT, Wynne ME, Slimmer LW.
    J Clin Psychiatry; 1984 Nov 01; 45(11):473-6. PubMed ID: 6386794
    [Abstract] [Full Text] [Related]

  • 33. The safety of desipramine.
    Werry JS.
    J Am Acad Child Adolesc Psychiatry; 1994 May 01; 33(4):588-91. PubMed ID: 8005913
    [No Abstract] [Full Text] [Related]

  • 34. Cardiovascular effects of desipramine in children and adults during exercise testing.
    Waslick BD, Walsh BT, Greenhill LL, Giardina EG, Sloan RP, Bigger JT, Bilich K.
    J Am Acad Child Adolesc Psychiatry; 1999 Feb 01; 38(2):179-86. PubMed ID: 9951217
    [Abstract] [Full Text] [Related]

  • 35. Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents.
    Wilens TE, Biederman J, Baldessarini RJ, Geller B, Schleifer D, Spencer TJ, Birmaher B, Goldblatt A.
    J Am Acad Child Adolesc Psychiatry; 1996 Nov 01; 35(11):1491-501. PubMed ID: 8936916
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Cardiovascular effects of desipramine in children and adolescents with attention deficit disorder.
    Biederman J, Gastfriend D, Jellinek MS, Goldblatt A.
    J Pediatr; 1985 Jun 01; 106(6):1017-20. PubMed ID: 3998940
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Cardiovascular effects of tricyclic antidepressants in childhood asthma: a case series and review.
    Wamboldt MZ, Yancey AG, Roesler TA.
    J Child Adolesc Psychopharmacol; 1997 Jun 01; 7(1):45-64. PubMed ID: 9192541
    [Abstract] [Full Text] [Related]

  • 40. The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine and desipramine.
    Singer HS, Brown J, Quaskey S, Rosenberg LA, Mellits ED, Denckla MB.
    Pediatrics; 1995 Jan 01; 95(1):74-81. PubMed ID: 7770313
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.